This announcement is a separate document:
武田薬品工業：第148回定時株主総会に向けたISSによる議決権行使推奨に対する武田薬品工業取締役会議長 飯島彰己からの意見表明について
Takeda Pharmaceutical: Opinions from Takeda Pharmaceuticals' Chairman of the Board, Akihiko Iijima, regarding the recommended exercise of voting rights by ISS for the 148th regular shareholders' meeting.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.